Chest
-
Lung Cancer Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The superior vena cava syndrome (SVCS) is caused by a gradual and insidious obtruction/compression of the superior vena cava (SVC). The most frequent etiology are malignant mediastinal tumors (80%) and lung cancer account for 75-80% of all these cases, with most of these being small-cell carcinomas. SVCS treatment depends on etiology. Aims: Characterization of lung carcinoma patients who developed SVCS and its subsequent treatment. ⋯ The following authors have nothing to disclose: Ines Sanches, Lígia Fernandes, Cláudia Lares dos Santos, Ana Figueiredo, Fernando BarataNo Product/Research Disclosure Information.
-
Cancer Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: Primary thyroid lymphoma is a rare neoplasm, representing 0.6 to 5% of thyroid malignancies. ⋯ The following authors have nothing to disclose: Francina Bolanos, Emmanuel Peña Gomezportugal, Enrique Guzman del alba, Patricio Santillán Doherty, Fortunato JuarezNo Product/Research Disclosure Information.
-
Asthma PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: to compare the perception of dyspnea (POD) during cycle exercise testing and airway challenge to adenosine in non-asmathic (group 1) fictitious asthmatic (group 2), and asthmatic (group 3) obese subjects. ⋯ overdiagnosis of asthma in obese subjects could be due to a greater PODDISCLOSURE: The following authors have nothing to disclose: Carlos Carpio, Francisco García-Río, David Romero, Isabel Fernández, Raul Galera, Carlos Villasante, Rodolfo Álvarez-SalaNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Monday, March 24, 2014 at 09:00 AM - 10:00 AMPURPOSE: Biomass smoke exposure is a risk factor for developing chronic obstructive pulmonary disease (COPD). Little is currently known concerning clinical differences between COPD due to tobacco and to biomass smoke. The purpose of this study was to search for clinical differences between both types of disease ⋯ Pilar Sanjuán: Consultant fee, speaker bureau, advisory committee, etc.: Almirall, Astra-Zeneca, Boehringer-Ingelheim Rafael Golpe: Consultant fee, speaker bureau, advisory committee, etc.: Novartis, GSK, Astra-Zeneca, Boehringer-Ingelheim, Almirall Luis Pérez-de-LLano: Grant monies (from industry related sources): Almirall, Consultant fee, speaker bureau, advisory committee, etc.: Almirall, Novertis, Astra-Zeneca, Boehringer-Ingelheim, GSK, Menarini Esteban Cano: Consultant fee, speaker bureau, advisory committee, etc.: GSK Olalla Castro-Añon: Consultant fee, speaker bureau, advisory committee, etc.: NovartisNo Product/Research Disclosure Information.
-
ILD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Sarcoidosis-related pulmonary hypertension (SRPH) is an entity associated with significant morbidity and mortality irrespective of disease severity, while the pathogenic mechanisms remain poorly understood. ⋯ The following authors have nothing to disclose: Vasileios Kouranos, Aggeliki Rapti, Elias Gialafos, Konstantina Aggeli, Petros Sfikakis, Nikolaos Koulouris, Athol Wells, George TzelepisNo Product/Research Disclosure Information.